A detailed history of Ifg Advisors, LLC transactions in Kempharm, Inc stock. As of the latest transaction made, Ifg Advisors, LLC holds 26,400 shares of KMPH stock, worth $130,416. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,400
Previous 18,700 41.18%
Holding current value
$130,416
Previous $92,000 41.3%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
N/A
7,700 Added 41.18%
26,400 $130,000
Q1 2024

Apr 24, 2024

BUY
N/A
5,800 Added 44.96%
18,700 $92,000
Q3 2023

Oct 31, 2023

SELL
N/A
-1,150 Reduced 8.19%
12,900 $63,000
Q2 2023

Jul 18, 2023

BUY
$4.94 - $6.29 $69,407 - $88,374
14,050 New
14,050 $69,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Ifg Advisors, LLC Portfolio

Follow Ifg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ifg Advisors, LLC with notifications on news.